For Questions 24 through 26, consider the following scenario. In 2023 the Modelo Virus (also known as MOVID-22) spread rapidly throughout the United States. By early 2024 the pharmaceutical company Toliver & Toliver developed an effective single dose vaccine, becoming a monopolist producer of this drug. The graph below illustrates Demand, Marginal Revenue (MR), and Marginal Costs of Production (MC) for Toliver & Toliver. Marginal Social Benefits (MSB) are also illustrated. Quantity is measured in millions of vaccinations. $ 74.50- Demand 49.20 34.30- MC=MSC 11.80 - MSB 7.40 d 0 quantity 98 MR 180 235 268 24. It appears as if production/consumption of this good generates A. a positive externality but no negative externality. B. a negative externality but no positive externality. C. both a positive externality and a negative externality. D neither a positive externality nor a negative externality. 25 To maximize profit, Toliver & Toliver would sell A. 98 units of output; $7.40 per unit. I and charge a price of B. 98 units of output; $34.30 per unit. C. 98 units of output; $49.20 per unit. D 180 units of output; $11.80 per unit. 26. If Toliver & Toliver was allowed to choose price and quantity to maximize profit, there would be a Deadweight Loss equal to A. "areas b+c" " areas atb+c" " areas botdte " "area g"